5-Trifluoromethyl-2-formylphenylboronic Acid

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Antimicrobial Research

Background:

• 2-Formylphenylboronic acids possess unique synthetic, structural, and application properties.
• Benzoxaboroles are known to inhibit microbial leucyl-tRNA synthetase (LeuRS), suggesting a mechanism for antifungal action.

Purpose of the Study:

• To synthesize and characterize 5-trifluoromethyl-2-formyl phenylboronic acid.
• To investigate its potential as an antimicrobial agent by evaluating its activity against various microorganisms.
• To explore its mechanism of action through docking studies with bacterial and fungal LeuRS enzymes.

Main Methods:

• Synthesis and characterization of 5-trifluoromethyl-2-formyl phenylboronic acid.
• In vitro antimicrobial susceptibility testing (Minimum Inhibitory Concentration - MIC).
• Molecular docking studies with Candida albicans and Escherichia coli LeuRS.

Main Results:

• The synthesized compound exhibits increased acidity due to the electron-withdrawing trifluoromethyl group.
• The compound demonstrated moderate antifungal activity against Candida albicans.
• Significant antibacterial activity was observed against Aspergillus niger, Escherichia coli, and Bacillus cereus, with a lower MIC than Tavaborole for Bacillus cereus.
• Docking studies suggested potential binding of the cyclic isomer to Candida albicans LeuRS and the open isomer to Escherichia coli LeuRS.

Conclusions:

• 5-Trifluoromethyl-2-formyl phenylboronic acid is a promising candidate for antimicrobial drug development.
• The compound's activity supports the potential of 2-formylphenylboronic acids as antibacterial agents.
• Further research into the mechanism of action and structure-activity relationships is warranted.